Changes in gait pattern as assessed by the GAITRitei™walkway system in MPS II patients undergoing enzyme replacement therapy

Journal of Inherited Metabolic Disease

Volumn 32, Issue SUPPL. 1, 2009, Pages

  Wood, M ^a   Cleary, M A ^b   Alderson, L ^a   Vellodi, A ^b  

^a Department of Physiotherapy Great Ormond Street Hospital for Children NHS Trust ^*  (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IDURONATE 2 SULFATASE; RECOMBINANT PROTEIN;

ARTICLE; BIOMECHANICS; CASE CONTROL STUDY; CHILD; ENZYME REPLACEMENT; GAIT; HUMAN; HUNTER SYNDROME; MALE; MUSCULOSKELETAL DISEASE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; WALKING;

BIOMECHANICS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENZYME REPLACEMENT THERAPY; GAIT; HUMANS; IDURONATE SULFATASE; MALE; MUCOPOLYSACCHARIDOSIS II; MUSCULOSKELETAL DISEASES; RECOMBINANT PROTEINS; WALKING;

EID: 84880974767     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-1103-2     Document Type: Article

References (20)

1. Alderson LM (2007) Measuring Normal Impaired Walking in Children Using the GAITRitei™ Walkway. University of Hertfordshire, Department of Paramedics Allied Health.
2. Bart AE Backus SI (2001) Biomechanics of gait. In: Nordin M, Frankel VH, eds. Basic Biomechanics of the Musculoskeletal System. Philadelphia: Lippincott Williams & Wilkins, pp. 438-455.
3. Bilney B, Morris M, Webster K (2003) Concurrent related validity of the GAITRitei™ walkway system for quantification of the spatial temporal parameters of gait. Gait Posture 17: 68-74. doi:10.1016/S0966-6362(02)00053-X. (Pubitemid 36132191)
4. Bladen M, Alderson L, Khair K, Liesner R, Green J, Main E (2007) Can early subclinical gait changes in children with haemophilia be identified using the GAITRitei™ walkway. Haemophilia 13 : 542-547. doi:10.1111/j.1365-2516. 2007.01429.x. (Pubitemid 47337994)
5. Chien SL, Lin SZ, Liang CC, et al (2006) The efficacy of quantitative gait analysis by the GAITRitei™ system in evaluation of parkinsonian bradykinesia. Parkinsonism. Relat Disord 12: 438-442. doi:10.1016/j.parkreldis. 2006.04.004.
6. Cole TJ, Green PJ (1992) Smoothing reference centile curves: the LMS method penalized likelihood. Stat Med 11: 1305-1319. doi:10.1002/sim.4780111005.
7. Cole TJ, Freeman JV, Preece MA (1998) British 1990 growth reference centiles for weight, height, body mass index head circumference fitted by maximum penalized likelihood. Stat Med 17: 407-429. doi:10.1002/(SICI)1097- 0258(19980228) 17:4〈407::AID-SIM742〉3.0.CO;2-L.
8. Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA (1995) Cross sectional stature weight reference curves for the UK, 1990. Arch Dis Child 73: 17-24. doi:10.1136/adc.73.1.17.
9. Haley SM, Fragala Pinkham MA, Dumas HM, Ni P, Skrinar AM, Cox GF (2006) A physical performance measure for individuals with mucopolysaccharidosis type I. Dev Med Child Neurol 48: 576-581. doi:10.1017/S0012162206001216.
10. Martin R, Beck M, Eng C, et al (2008) Recognition diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics 121: e377-e386. doi:10.1542/peds.2007-1350. (Pubitemid 351198459)
11. McDonough AL, Batavia M, Chen FC, Kwon S, Ziai J (2001) The validity reliability of the GAITRite™ system's measurements: a preliminary evaluation. Arch Phys Med Rehabil 82: 419-425. doi:10.1053/apmr.2001.19778. (Pubitemid 32199577)
12. Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281: 249-254. doi:10.1001/jama.281.3.249. (Pubitemid 29058114)
13. Muenzer J, Gucsavas-Calikoglu M, McCandless SE, Schuetz TJ, Kimura A (2007) A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). Mol Genet Metab 90: 329-337. doi:10.1016/j.ymgme.2006.09.001. (Pubitemid 46241902)
14. Oeffinger D, Brauch B, Cranfill S, et al (1999) Comparison of gait with without shoes in children. Gait Posture 9: 95-100. doi:10.1016/S0966-6362(99) 00005-3. (Pubitemid 29248909)
15. Parmar V, Shyam Kumar AJ, Harper WM (2006) Reliability of the GAITRitei™ walkway system for the quantification of temporo-spatial parameters of gait in young older people. Gait Posture 23: 523-525. doi:10.1016/j.gaitpost.2005.06.001.
16. Smith W Rome K (1996) Reliability of walking speed in podiatric patients. Gait Posture 4(2): 130-135. doi:10.1016/0966-6362(95)01042-4. (Pubitemid 26103058)
17. Webster KE, Wittwer JE, Feller JA (2005) Validity of the GAITRite™ walkway system for the measurement of averaged individual step parameters of gait. Gait Posture 22: 317-321. doi:10.1016/j.gaitpost.2004.10.005. (Pubitemid 41586104)
18. Whittle MW (2007) Gait Analysis: An Introduction, 4th edn. Oxford: Butterworth-Heinemann, Elsevier Health Sciences.
19. Wondra VC, Pitetti KH, Beets MW (2007) Gait parameters in children with motor disabilities using an electronic walkway system: assessment of reliability. Pediatr Phys Ther 19: 326-331. doi:10.1097/PEP.0b013e3181577d6d. (Pubitemid 351339644)
20. Wraith JE (2008) Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II. Acta Paediatr Suppl 97: 76-78. doi:10.1111/j.1651-2227.2008.00661.x.